MetLife Investment Management’s ReposiTrak TRAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,482
Closed -$55.4K 2842
2025
Q4
$55.4K Sell
4,482
-2,058
-31% -$29.2K ﹤0.01% 2721
2025
Q3
$96.9K Sell
6,540
-354
-5% -$6.14K ﹤0.01% 2666
2025
Q2
$135K Hold
6,894
﹤0.01% 2387
2025
Q1
$140K Hold
6,894
﹤0.01% 2379
2024
Q4
$153K Hold
6,894
﹤0.01% 2434
2024
Q3
$127K Buy
6,894
+3,885
+129% +$70.8K ﹤0.01% 2528
2024
Q2
$46K Buy
+3,009
New +$48.5K ﹤0.01% 2769

Other funds holding TRAK

MetLife Investment Management's TRAK Position: Q1 2026 in Review

MetLife Investment Management sold out of ReposiTrak (TRAK) in Q1 2026, closing a stake of 4,482 shares — an estimated $55.4K sold.

MetLife Investment Management first reported a position in TRAK in Q2 2024 and held it in 7 quarters. The position peaked at $153K in Q4 2024. 111 funds tracked by Wall St. Rank hold TRAK as of Q1 2026.

  • MetLife Investment Management reported no remaining ReposiTrak position as of Q1 2026 after selling out during the quarter.
  • MetLife Investment Management sold 4,482 ReposiTrak shares in Q1 2026, an estimated $55.4K.
  • MetLife Investment Management first reported a position in ReposiTrak in Q2 2024 and held it in 7 quarters.
  • MetLife Investment Management's ReposiTrak position peaked at $153K in Q4 2024.
  • 111 funds tracked by Wall St. Rank held ReposiTrak as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.